رفتن به محتوا

تداخل‌های دارویی

Enzalutamide + Mavacamten

شدت: منع مصرف

Enzalutamide and Mavacamten: contraindicated interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Mavacamten is cleared by CYP2C19 and CYP3A4, and enzalutamide induces both, lowering exposure and reducing therapeutic effect on outflow obstruction. Labeling advises against use with strong inducers of these enzymes.

معنای این تداخل به زبان ساده

Enzalutamide and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Enzalutamide belongs to Endocrine; Mavacamten belongs to Cardiovascular.

سطح شواهد: Moderate

چرا رخ می‌دهد

Induction of CYP2C19 and CYP3A4 by enzalutamide increases mavacamten clearance.

اقدام لازم

Avoid the combination; if enzalutamide is started or stopped in a mavacamten patient, check LVEF and gradient by echocardiography and adjust the dose.

از داروساز چه بپرسید

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Enzalutamide و Mavacamten، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Enzalutamide with Mavacamten?

MediHelp rates the interaction as contraindicated. Enzalutamide and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Mavacamten is cleared by CYP2C19 and CYP3A4, and enzalutamide induces both, lowering exposure and reducing therapeutic effect on outflow obstruction. Labeling advises against use with strong inducers of these enzymes.

How serious is the interaction between Enzalutamide and Mavacamten?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; if enzalutamide is started or stopped in a mavacamten patient, check LVEF and gradient by echocardiography and adjust the dose.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود